Earnings
AVTX
2.540
+9.48%
0.220
Currencies: USD
Items
Total Revenue
Revenue
Cost of Revenue
Gross Profit
Marketing and Administrative Expenses
Research and Development Costs
Financial Expenses
Depreciation and Amortization
Other Expenses
Total Operating Expenses
Asset Impairments
Operating Income
Interest Income
Assets Disposal
Other Non-operating Net Income
Non-operating Income
Net Income Before Taxes
Provision for Income Taxes
Net Income
Minority Interests
Net Income Attributable to Shareholders
Net Income Attributable to Common Equities
Net Income from Discontinued Operations
Basic EPS
Diluted EPS
FY 2020-12-31
6.70M
6.70M
300.20K
6.40M
19.76M
32.19M
0.00
--
0.00
79.54M
--
-72.84M
5.26M
--
409.85K
--
-67.18M
-2.79M
-64.38M
--
-64.38M
-64.38M
883.78K
--
-0.97
FY 2019-12-31
6.75M
6.75M
566.52K
-1.13M
11.61M
11.76M
-1.26M
--
-1.26M
22.89M
--
-16.14M
171.37K
--
-24.40K
--
-15.99M
280.32K
-16.27M
--
-16.27M
-16.27M
198.21K
--
-0.38
FY 2018-12-31
7.03M
7.03M
3.26M
3.77M
11.06M
5.79M
-110.92K
--
-110.92K
42.41M
--
-35.38M
41.27K
--
13.66K
--
-35.32M
-49.47K
-35.27M
--
-35.27M
-36.93M
-4.78M
--
-1.06
FY 2017-12-31
27.81M
27.81M
635.65K
27.18M
8.91M
4.37M
--
--
--
13.92M
--
13.89M
-53.64K
--
--
--
13.84M
-233.48K
14.07M
--
14.07M
14.07M
-2.20M
--
0.75
FY 2016-12-31
1.15M
1.15M
--
--
7.08M
10.15M
--
--
--
17.23M
--
-16.08M
-391.55K
--
--
--
-16.47M
--
-16.47M
--
-16.47M
-16.47M
--
--
-1.87

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out AVTX latest quarterly and annual financial reports. There are also past financial reports for you to reference. You can analyze Avalo Therapeutics Inc recent business situations from balance sheets, income statements, cash flow statements and other tables. This information may help you make smarter investment decisions.